Guidelines for lowering lipids to reduce coronary artery disease risk: A comparison of rosuvastatin with atorvastatin, pravastatin, and simvastatin for achieving lipid-lowering goals - Discussion

被引：0
|
作者：
Davidson, MH [1 ]
Wood, DA
Paoletti, R
Hobbs, R
Shepherd, J
Brown, WV
Hunninghake, DB
McKenney, JM
机构：
[1] Chicago Ctr Clin Res, Chicago, IL USA
[2] Charing Cross Hosp, Natl Heart & Lung Inst, London, England
[3] Univ Milan, Milan, Italy
[4] Univ Birmingham, Birmingham, W Midlands, England
[5] Univ Glasgow, Glasgow, Lanark, Scotland
[6] Emory Univ, Sch Med, Atlanta, GA USA
[7] Univ Minnesota, Minneapolis, MN USA
[8] Natl Clin Res, Richmond, VA USA
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 2003年 / 91卷 / 5A期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：17C / 19C
页数：3
相关论文
共 50 条
  • [21] Comparison of Lipid-Lowering Medications and Risk for Cardiovascular Disease in Diabetes
    Cavallari, Ilaria
    Delli Veneri, Alessia
    Maddaloni, Ernesto
    Melfi, Rosetta
    Patti, Giuseppe
    Napoli, Nicola
    Pozzilli, Paolo
    Di Sciascio, Germano
    CURRENT DIABETES REPORTS, 2018, 18 (12)
  • [22] Comparison of Lipid-Lowering Medications and Risk for Cardiovascular Disease in Diabetes
    Ilaria Cavallari
    Alessia Delli Veneri
    Ernesto Maddaloni
    Rosetta Melfi
    Giuseppe Patti
    Nicola Napoli
    Paolo Pozzilli
    Germano Di Sciascio
    Current Diabetes Reports, 2018, 18
  • [23] Lipid-lowering and antiaggregatory efficacy of atorvastatin in coronary heart disease patients with combined hyperlipidemia
    Viigimaa, M
    Välkman, R
    ATHEROSCLEROSIS, 1999, 144 : 24 - 24
  • [24] Intensive lipid-lowering with atorvastatin for secondary prevention in patients after coronary artery bypass surgery
    Shah, Sanjiv J.
    Waters, David D.
    Barter, Philip
    Kastelein, John J. P.
    Shepherd, James
    Wenger, Nanette K.
    DeMicco, David A.
    Breazna, Andrei
    LaRosa, John C.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (20) : 1938 - 1943
  • [25] Early Effect of Lipid-Lowering Therapy With Pitavastatin on Regression of Coronary Atherosclerotic Plaque - Comparison With Atorvastatin -
    Toi, Toru
    Taguchi, Isao
    Yoneda, Shuichi
    Kageyama, Michiya
    Kikuchi, Akiko
    Tokura, Michiaki
    Kanaya, Tomoaki
    Abe, Shichiro
    Matsuda, Ryuko
    Kaneko, Noboru
    CIRCULATION JOURNAL, 2009, 73 (08) : 1466 - 1472
  • [26] Lipid-lowering treatment in coronary artery disease: a survey in an ambulatory outpatient clinic
    Harder, S
    Mohr, O
    Klepzig, H
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2001, 39 (12) : 534 - 538
  • [27] LIPID-LOWERING THERAPY FOR CORONARY-ARTERY DISEASE - WHO AND HOW TO TREAT
    NASH, DT
    POSTGRADUATE MEDICINE, 1983, 74 (05) : 308 - 309
  • [28] Lipid-lowering therapy in patients with coronary artery disease: Sex or age bias?
    Sgadari, A
    Incalzi, RA
    Onder, G
    Pedone, C
    Gambassi, G
    ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (17) : 2684 - +
  • [29] Intensive lipid-lowering with statins unnecessary with stable coronary artery disease (IDEAL)
    不详
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2006, 73 (02) : 160 - 160
  • [30] Is aggressive lipid-lowering therapy preferable to angioplasty in stable coronary artery disease?
    Ellis, PM
    MEDICAL JOURNAL OF AUSTRALIA, 2001, 175 (09) : 492 - 493
12345